<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Gubra A/s — News on 6ix</title>
<link>https://6ix.com/company/gubra-as</link>
<description>Latest news and press releases for Gubra A/s on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 10 Nov 2025 20:45:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/gubra-as" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d51a8bbeedb30cb6f65708.webp</url>
<title>Gubra A/s</title>
<link>https://6ix.com/company/gubra-as</link>
</image>
<item>
<title>Reporting Of Transactions Made By Persons Discharging Managerial Responsibilities And Persons Closely Associated With Them In Gubra A/S' Shares</title>
<link>https://6ix.com/company/gubra-as/news/reporting-of-transactions-made-by-persons-discharging-managerial-responsibilities-and-persons-closely-associated-with-them-in-gubra-as-shares</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/reporting-of-transactions-made-by-persons-discharging-managerial-responsibilities-and-persons-closely-associated-with-them-in-gubra-as-shares</guid>
<pubDate>Mon, 10 Nov 2025 20:45:00 GMT</pubDate>
<description>HORSHOLM, DK / ACCESS Newswire / November 10, 2025 / Gubra (CPH:GUBRA) Pursuant to the Market Abuse Regulation article 19, Gubra A/S, CVR no. 30514041 (the "Company") hereby notifies receipt of information of the following transactions made by persons ...</description>
</item>
<item>
<title>Trading Statement Q3-2025: Expanding Our R&D Activities</title>
<link>https://6ix.com/company/gubra-as/news/trading-statement-q3-2025-expanding-our-randd-activities</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/trading-statement-q3-2025-expanding-our-randd-activities</guid>
<pubDate>Fri, 07 Nov 2025 06:45:00 GMT</pubDate>
<description>HØRSHOLM, DK / ACCESS Newswire / November 7, 2025 / Gubra (CPH:GUBRA) - Today, Gubra releases its results for the third quarter of 2025. In September, Gubra welcomed Markus Rohrwild as our new CEO. The third quarter has been characterized by expansion ...</description>
</item>
<item>
<title>Record Earnings for Gubra; Revised Outlook for the CRO Business</title>
<link>https://6ix.com/company/gubra-as/news/record-earnings-for-gubra-revised-outlook-for-the-cro-business</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/record-earnings-for-gubra-revised-outlook-for-the-cro-business</guid>
<pubDate>Thu, 06 Nov 2025 16:30:00 GMT</pubDate>
<description>HORSHOLM, DENMARK / ACCESS Newswire / November 6, 2025 /Revenue and earnings for Gubra (CPH:GUBRA) reached record-high levels in the first nine months of 2025. Group revenue and adjusted EBIT amounted to DKK 2.6 billion and DKK 2.3 billion, respectively, ...</description>
</item>
<item>
<title>Gubra Announces Completion of Solar & Battery Park</title>
<link>https://6ix.com/company/gubra-as/news/gubra-announces-completion-of-solar-and-battery-park</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/gubra-announces-completion-of-solar-and-battery-park</guid>
<pubDate>Tue, 02 Sep 2025 05:50:00 GMT</pubDate>
<description>HØRSHOLM, DK / ACCESS Newswire / September 2, 2025 / Gubra (CPH:GUBRA) - Gubra announces the upcoming launch of a 2MW solar and battery park in Sorø, Denmark. The park, completed and currently awaiting grid connection, is the latest initiative under ...</description>
</item>
<item>
<title>Interim Report H1 2025: Group Revenue and Earnings Record-High</title>
<link>https://6ix.com/company/gubra-as/news/interim-report-h1-2025-group-revenue-and-earnings-record-high</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/interim-report-h1-2025-group-revenue-and-earnings-record-high</guid>
<pubDate>Thu, 21 Aug 2025 05:50:00 GMT</pubDate>
<description>HØRSHOLM, DK / ACCESS Newswire / August 21, 2025 / Gubra (CPH:GUBRA) - Today, Gubra released its interim report for the first half of 2025. Group revenue and EBIT in the first half of 2025 were record-high and amounted to DKK 2.5 billion and DKK 2.3 ...</description>
</item>
<item>
<title>Record Quarter for Gubra, but Revised Outlook for the CRO Business</title>
<link>https://6ix.com/company/gubra-as/news/record-quarter-for-gubra-but-revised-outlook-for-the-cro-business</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/record-quarter-for-gubra-but-revised-outlook-for-the-cro-business</guid>
<pubDate>Wed, 20 Aug 2025 15:45:00 GMT</pubDate>
<description>HORSHOLM, DENMARK / ACCESS Newswire / August 20, 2025 / Revenue and earnings for Gubra Group (CPH:GUBRA) have been record-high in the second quarter of 2025 driven by the outlicensing deal with AbbVie in our Discovery & Partnerships business. While ...</description>
</item>
<item>
<title>Markus Rohrwild Appointed New CEO of Gubra in a Planned Succession Process</title>
<link>https://6ix.com/company/gubra-as/news/markus-rohrwild-appointed-new-ceo-of-gubra-in-a-planned-succession-process</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/markus-rohrwild-appointed-new-ceo-of-gubra-in-a-planned-succession-process</guid>
<pubDate>Tue, 12 Aug 2025 09:00:00 GMT</pubDate>
<description>HØRSHOLM, DK / ACCESS Newswire / August 12, 2025 / Gubra (CPH:GUBRA) Following a planned succession process, the Board of Directors of Gubra has appointed Markus Rohrwild as the new CEO of the company effective September 8, 2025. Henrik Blou will ...</description>
</item>
<item>
<title>Gubra Shares are Traded Ex-Dividend</title>
<link>https://6ix.com/company/gubra-as/news/gubra-shares-are-traded-ex-dividend</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/gubra-shares-are-traded-ex-dividend</guid>
<pubDate>Mon, 30 Jun 2025 08:10:00 GMT</pubDate>
<description>HØRSHOLM, DK / ACCESS Newswire / June 30, 2025 / Gubra (CPH:GUBRA) Today, 30 June 2025, Gubra shares are traded ex-dividend of DKK 61.20. Contacts at Gubra Media: Sofia Pitt Boserup, [email protected] , +45 4188 9586Investors: Kristian Borbos, [email protected] ...</description>
</item>
<item>
<title>Course of Gubra A/S' Extraordinary General Meeting Regarding Extraordinary Dividend</title>
<link>https://6ix.com/company/gubra-as/news/course-of-gubra-as-extraordinary-general-meeting-regarding-extraordinary-dividend</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/course-of-gubra-as-extraordinary-general-meeting-regarding-extraordinary-dividend</guid>
<pubDate>Fri, 27 Jun 2025 11:30:00 GMT</pubDate>
<description>HORSHOLM, DENMARK / ACCESS Newswire / June 27, 2025 / On Friday, 27 June 2025 at 12:00 am (CEST), an extraordinary general meeting of Gubra A/S (CPH:GUBRA) (the "Company") was held at the Company's registered address Hørsholm Kongevej 11B, DK-2970 ...</description>
</item>
<item>
<title>Notice To Convene Extraordinary General Meeting Regarding Extraordinary Dividend</title>
<link>https://6ix.com/company/gubra-as/news/notice-to-convene-extraordinary-general-meeting-regarding-extraordinary-dividend</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/notice-to-convene-extraordinary-general-meeting-regarding-extraordinary-dividend</guid>
<pubDate>Tue, 03 Jun 2025 05:50:00 GMT</pubDate>
<description>HØRSHOLM, DK / ACCESS Newswire / June 3, 2025 / Gubra (CPH:GUBRA) Notice to convene extraordinary GENERAL MEETING REGARDING EXTRAORDINARY DIVIDEND GUBRA A/SCVR NO. 30 51 40 41 To the shareholders of Gubra A/S (CVR no. 30 51 40 41), notice is hereby ...</description>
</item>
<item>
<title>Trading Statement Q1-2025: A Landmark Deal for GUBamy</title>
<link>https://6ix.com/company/gubra-as/news/trading-statement-q1-2025-a-landmark-deal-for-gubamy</link>
<guid isPermaLink="true">https://6ix.com/company/gubra-as/news/trading-statement-q1-2025-a-landmark-deal-for-gubamy</guid>
<pubDate>Fri, 09 May 2025 06:00:00 GMT</pubDate>
<description>HØRSHOLM, DK / ACCESS Newswire / May 9, 2025 / Gubra (CPH:GUBRA) - Today, Gubra releases its results for the first quarter of 2025. The key development in the quarter was the out-licensing agreement to AbbVie for our anti-obesity asset GUBamy (Amylin). ...</description>
</item>
</channel>
</rss>